πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 2,639 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 11426464

Engineered primate cystine/cysteine degrading enzymes as antineogenic agents

The Board of Regents of the University of Texas System Β· Granted Tue Aug 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11426420

Inhibitors of short-chain dehydrogenase activity for treating coronary disorders

The Board of Regents of the University of Texas System Β· Granted Tue Aug 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11426366

Compositions and methods for treating motor disorders

Arizona Board of Regents on Behalf of the University of Arizona Β· Granted Tue Aug 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11419888

Composition and method for promoting reduction of heat stress in animals

Arizona Board of Regents on Behalf of the University of Arizona Β· Granted Tue Aug 23 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 18 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11421010

T cells expressing membrane-anchored IL-12 for the treatment of cancer

The Board of Regents of the University of Texas System Β· Granted Tue Aug 23 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 18 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11413329

Cancer cell trap

The Board of Regents of the University of Texas System Β· Granted Tue Aug 16 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 11 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11413336

Coccidioides antigens and methods of their use

The Board of Regents of the University of Texas System Β· Granted Tue Aug 16 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 11 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11414455

Toll-like receptor 2 ligands and methods of making and using thereof

Arizona Board of Regents on Behalf of the University of Arizona Β· Granted Tue Aug 16 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 11 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11414458

Identification of MHC class I phospho-peptide antigens from breast cancer utilizing SHLA t

The Board of Regents of the University of Oklahoma Β· Granted Tue Aug 16 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 11 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11413240

Methylene blue solution for the treatment of oral lesions

The Board of Regents of the University of Texas System Β· Granted Tue Aug 16 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 11 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11406722

Nanodroplets with improved properties

The Board of Regents of the University of Texas System Β· Granted Tue Aug 09 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 04 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11407752

Substituted 4,6-dihydrospiro[[1,2,3]triazolo[4,5-b]pyridine-7,3β€²-indoline]-2β€²,5(3H)-dione

The Board of Regents of the University of Texas System Β· Granted Tue Aug 09 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 04 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11406643

Targeting kinases for the treatment of cancer metastasis

The Board of Regents of the University of Texas System Β· Granted Tue Aug 09 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 04 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11400096

Small molecules for the treatment of autoimmune disorders

The Board of Regents of the University of Texas System Β· Granted Tue Aug 02 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11400108

Cyclic dinucleotides as agonists of stimulator of interferon gene dependent signalling

The Board of Regents of the University of Texas System Β· Granted Tue Aug 02 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11401510

Generation of airway basal stem cells from human pluripotent stem cells

The Board of Regents of the University of Texas System Β· Granted Tue Aug 02 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11395850

RSV vaccines and methods of production and use thereof

The Board of Regents for Oklahoma State University Β· Granted Tue Jul 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11395838

Methods for enhancing immune checkpoint blockade therapy by modulating the microbiome

The Board of Regents of the University of Texas System Β· Granted Tue Jul 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11396647

Human methylthioadenosine/adenosine depleting enzyme variants for cancer therapy

The Board of Regents of the University of Texas System Β· Granted Tue Jul 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11397188

Method of detecting an APP Alzheimer's disease marker peptide in patients with Alzheimer's

The Board of Regents of the University of Texas System Β· Granted Tue Jul 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11390605

Substituted pyrimidine compounds as multifunctional radical quenchers and their uses

ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY Β· Granted Tue Jul 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11389433

BRD4 inhibitor treatment of IgE-mediated diseases

The Board of Regents of the University of Texas System Β· Granted Tue Jul 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11389386

Photochemically stable, non-leaching, bridged polysilsesquioxane based sunscreens

Arizona Board of Regents on Behalf of the University of Arizona Β· Granted Tue Jul 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11389459

Texaphyrin-Pt(IV) conjugates and compositions for use in overcoming platinum resistance

The Board of Regents of the University of Texas System Β· Granted Tue Jul 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted